Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
Trial details
- Registry ID
- NCT05550207
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as AXS-07; meloxicam-rizatriptan
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)NCT05550207 | AXSM | Phase 3 | Completed | 2024-11-27Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |